Sunday, August 25, 2019

Alkem Lab gets Form 483 with 4 observations for St. Louis facility

The Company shall put together a detailed response with adequate corrective and preventive measures to address the USFDA observations for the facility located at St. Louis, Fenton Park, USA and the same is proposed to be filed within the timeline stipulated by USFDA, the company said in the filing.

from India Infoline News Service https://ift.tt/2HqyND7

No comments:

Post a Comment